Cargando…
The CentriMag Centrifugal Blood Pump as a Benchmark for In Vitro Testing of Hemocompatibility in Implantable Ventricular Assist Devices
Implantable ventricular assist devices (VADs) have proven efficient in advanced heart failure patients as a bridge-to-transplant or destination therapy. However, VAD usage often leads to infection, bleeding, and thrombosis, side effects attributable to the damage to blood cells and plasma proteins....
Autores principales: | Chan, Chris HH, Pieper, Ina Laura, Hambly, Rebecca, Radley, Gemma, Jones, Alyssa, Friedmann, Yasmin, Hawkins, Karl M, Westaby, Stephen, Foster, Graham, Thornton, Catherine A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338790/ https://www.ncbi.nlm.nih.gov/pubmed/25066768 http://dx.doi.org/10.1111/aor.12351 |
Ejemplares similares
-
Hemocompatibility of new magnetically-levitated centrifugal pump technology compared to the CentriMag adult pump
por: Schibilsky, David, et al.
Publicado: (2020) -
Computational fluid dynamics analysis and experimental hemolytic performance of three clinical centrifugal blood pumps: Revolution, Rotaflow and CentriMag
por: Han, Dong, et al.
Publicado: (2022) -
Use of CentriMag for refractory cardiogenic shock in a puerperal woman: case report
por: Pêgo-Fernandes, Paulo Manuel, et al.
Publicado: (2021) -
How to Optimize ECLS Results beyond Ventricular Unloading: From ECMO to CentriMag(®) eVAD
por: Tarzia, Vincenzo, et al.
Publicado: (2022) -
Biventricular Levitronix CentriMag Assist Device: A “Bridge to Recovery” Solution in Patients with Acute Fulminant Myocarditis
por: Vollroth, Marcel, et al.
Publicado: (2012)